Summary of HR 3688: Protecting Children from Experimentation Act of 2025

Purpose and Intent

The Protecting Children from Experimentation Act of 2025 (HR 3688) aims to safeguard children from being subjected to medical experimentation without appropriate oversight and consent. The bill seeks to establish clear guidelines and restrictions regarding the types of medical procedures and treatments that can be administered to minors, particularly those that may involve experimental drugs or therapies.

Key Provisions

• Prohibition of Experimental Treatments: The bill prohibits the administration of experimental medical treatments or procedures to individuals under the age of 18 unless specific criteria are met.

• Informed Consent Requirements: It mandates that informed consent must be obtained from a parent or legal guardian before any experimental treatment can be administered to a minor.

• Oversight Mechanisms: The legislation calls for the establishment of oversight mechanisms to ensure compliance with the new regulations, including reporting requirements for healthcare providers.

• Penalties for Non-Compliance: The bill outlines penalties for healthcare providers who violate the provisions, which may include fines and potential loss of medical licenses.

Affected Parties

• Children and Minors: The primary focus of the bill is to protect children under 18 from potentially harmful experimental treatments.

• Healthcare Providers: Medical professionals and institutions that administer treatments to minors will be directly impacted by the new regulations and compliance requirements.

• Parents and Guardians: The bill emphasizes the role of parents and guardians in the decision-making process regarding their children's medical care, particularly concerning experimental treatments.

Legislative Process and Timeline

• Introduced: The bill was introduced in the House on June 3, 2025.

• Committee Referral: Following its introduction, HR 3688 was referred to the House Committee on the Judiciary for further consideration on the same day.

Sponsors

The bill is sponsored by Doug LaMalfa and has multiple cosponsors, including:
- Gary J. Palmer
- Claudia Tenney
- Jodey C. Arrington
- Glenn Grothman
- David Rouzer
- Paul A. Gosar
- John R. Carter
- Diana Harshbarger
- Mary E. Miller
- Lauren Boebert
- Bruce Westerman
- Brian Babin
- Troy E. Nehls
- Mike Bost

Conclusion

HR 3688 seeks to establish critical protections for minors in the context of medical experimentation, ensuring that parents or guardians are involved in the decision-making process. As the bill progresses through the legislative process, it will be essential to monitor its developments and potential implications for healthcare practices involving children.